Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 23 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 1040. Clear
Clear
Q1
AMGEN, INC. for AMGEN INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → Q1
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Copyright/Patent/Trademark, Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs
View → Q1
COUNCIL FOR INNOVATION PROMOTION (C4IP) for COUNCIL FOR INNOVATION PROMOTION (C4IP)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q4
COUNCIL FOR INNOVATION PROMOTION (C4IP) for COUNCIL FOR INNOVATION PROMOTION (C4IP)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q4
AMGEN, INC. for AMGEN INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → Q4
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View → 1A
COUNCIL FOR INNOVATION PROMOTION (C4IP) for COUNCIL FOR INNOVATION PROMOTION (C4IP)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Trade (domestic/foreign)
View → 2A
AMGEN, INC. for AMGEN INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → Q3
AMGEN, INC. for AMGEN INC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → 2A
COUNCIL FOR INNOVATION PROMOTION (C4IP) for COUNCIL FOR INNOVATION PROMOTION (C4IP)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q3
COUNCIL FOR INNOVATION PROMOTION (C4IP) for COUNCIL FOR INNOVATION PROMOTION (C4IP)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q3
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View → Q2
SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) for SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL)
2nd Quarter (Apr 1 - June 30) 2025 · Virginia · House · Senate
Small Business
View → Q2
AMGEN, INC. for AMGEN INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → Q2
COUNCIL FOR INNOVATION PROMOTION (C4IP) for COUNCIL FOR INNOVATION PROMOTION (C4IP)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q2
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · Senate · $220,000.00 income
Copyright/Patent/Trademark, Health Issues
View → Q2
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View → Q2
T1INTERNATIONAL USA for T1INTERNATIONAL USA
2nd Quarter (Apr 1 - June 30) 2025 · Maine · House · Senate
Health Issues
View → Q1
AMGEN, INC. for AMGEN INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → Q1
COUNCIL FOR INNOVATION PROMOTION (C4IP) for COUNCIL FOR INNOVATION PROMOTION (C4IP)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q1
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · $420,000.00 income
Copyright/Patent/Trademark, Health Issues
View → Q1
SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) for SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL)
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate
Small Business
View → Q1
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem